Global Pediatric Psoriasis Treatment Supply, Demand and Key Producers, 2023-2029
The global Pediatric Psoriasis Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
This report studies the global Pediatric Psoriasis Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pediatric Psoriasis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Psoriasis Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pediatric Psoriasis Treatment total production and demand, 2018-2029, (K Units)
Global Pediatric Psoriasis Treatment total production value, 2018-2029, (USD Million)
Global Pediatric Psoriasis Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pediatric Psoriasis Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pediatric Psoriasis Treatment domestic production, consumption, key domestic manufacturers and share
Global Pediatric Psoriasis Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pediatric Psoriasis Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pediatric Psoriasis Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pediatric Psoriasis Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Amgen, Johnson and Johnson, Novartis AG, Eli Lilly and Company, AstraZeneca, Celgene Corporation, UCB and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Psoriasis Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pediatric Psoriasis Treatment Market, By Region:
1. How big is the global Pediatric Psoriasis Treatment market?
2. What is the demand of the global Pediatric Psoriasis Treatment market?
3. What is the year over year growth of the global Pediatric Psoriasis Treatment market?
4. What is the production and production value of the global Pediatric Psoriasis Treatment market?
5. Who are the key producers in the global Pediatric Psoriasis Treatment market?
6. What are the growth factors driving the market demand?
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
This report studies the global Pediatric Psoriasis Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pediatric Psoriasis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Psoriasis Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pediatric Psoriasis Treatment total production and demand, 2018-2029, (K Units)
Global Pediatric Psoriasis Treatment total production value, 2018-2029, (USD Million)
Global Pediatric Psoriasis Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pediatric Psoriasis Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pediatric Psoriasis Treatment domestic production, consumption, key domestic manufacturers and share
Global Pediatric Psoriasis Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pediatric Psoriasis Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pediatric Psoriasis Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pediatric Psoriasis Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Amgen, Johnson and Johnson, Novartis AG, Eli Lilly and Company, AstraZeneca, Celgene Corporation, UCB and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Psoriasis Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pediatric Psoriasis Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Topical Treatment
- Systemic Treatment
- Psoriasis Vulgaris
- Pustular Psoriasis
- Erythrodermic Psoriasis
- Arthropathic Psoriasis
- AbbVie
- Amgen
- Johnson and Johnson
- Novartis AG
- Eli Lilly and Company
- AstraZeneca
- Celgene Corporation
- UCB
- Merck
- Boehringer Ingelheim
- LEO Pharma
- Qingdao Vland Biotech
- Yunnan Botanee Bio-Technology
- Furen Group
- Jiangsu Kanion Pharmaceutical
- Tianjin Pacific Pharmaceutical
1. How big is the global Pediatric Psoriasis Treatment market?
2. What is the demand of the global Pediatric Psoriasis Treatment market?
3. What is the year over year growth of the global Pediatric Psoriasis Treatment market?
4. What is the production and production value of the global Pediatric Psoriasis Treatment market?
5. Who are the key producers in the global Pediatric Psoriasis Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pediatric Psoriasis Treatment Introduction
1.2 World Pediatric Psoriasis Treatment Supply & Forecast
1.2.1 World Pediatric Psoriasis Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Pediatric Psoriasis Treatment Production (2018-2029)
1.2.3 World Pediatric Psoriasis Treatment Pricing Trends (2018-2029)
1.3 World Pediatric Psoriasis Treatment Production by Region (Based on Production Site)
1.3.1 World Pediatric Psoriasis Treatment Production Value by Region (2018-2029)
1.3.2 World Pediatric Psoriasis Treatment Production by Region (2018-2029)
1.3.3 World Pediatric Psoriasis Treatment Average Price by Region (2018-2029)
1.3.4 North America Pediatric Psoriasis Treatment Production (2018-2029)
1.3.5 Europe Pediatric Psoriasis Treatment Production (2018-2029)
1.3.6 China Pediatric Psoriasis Treatment Production (2018-2029)
1.3.7 Japan Pediatric Psoriasis Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pediatric Psoriasis Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pediatric Psoriasis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pediatric Psoriasis Treatment Demand (2018-2029)
2.2 World Pediatric Psoriasis Treatment Consumption by Region
2.2.1 World Pediatric Psoriasis Treatment Consumption by Region (2018-2023)
2.2.2 World Pediatric Psoriasis Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Pediatric Psoriasis Treatment Consumption (2018-2029)
2.4 China Pediatric Psoriasis Treatment Consumption (2018-2029)
2.5 Europe Pediatric Psoriasis Treatment Consumption (2018-2029)
2.6 Japan Pediatric Psoriasis Treatment Consumption (2018-2029)
2.7 South Korea Pediatric Psoriasis Treatment Consumption (2018-2029)
2.8 ASEAN Pediatric Psoriasis Treatment Consumption (2018-2029)
2.9 India Pediatric Psoriasis Treatment Consumption (2018-2029)
3 WORLD PEDIATRIC PSORIASIS TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pediatric Psoriasis Treatment Production Value by Manufacturer (2018-2023)
3.2 World Pediatric Psoriasis Treatment Production by Manufacturer (2018-2023)
3.3 World Pediatric Psoriasis Treatment Average Price by Manufacturer (2018-2023)
3.4 Pediatric Psoriasis Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pediatric Psoriasis Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pediatric Psoriasis Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Pediatric Psoriasis Treatment in 2022
3.6 Pediatric Psoriasis Treatment Market: Overall Company Footprint Analysis
3.6.1 Pediatric Psoriasis Treatment Market: Region Footprint
3.6.2 Pediatric Psoriasis Treatment Market: Company Product Type Footprint
3.6.3 Pediatric Psoriasis Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pediatric Psoriasis Treatment Production Value Comparison
4.1.1 United States VS China: Pediatric Psoriasis Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pediatric Psoriasis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pediatric Psoriasis Treatment Production Comparison
4.2.1 United States VS China: Pediatric Psoriasis Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pediatric Psoriasis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pediatric Psoriasis Treatment Consumption Comparison
4.3.1 United States VS China: Pediatric Psoriasis Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pediatric Psoriasis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pediatric Psoriasis Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pediatric Psoriasis Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023)
4.5 China Based Pediatric Psoriasis Treatment Manufacturers and Market Share
4.5.1 China Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pediatric Psoriasis Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023)
4.6 Rest of World Based Pediatric Psoriasis Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pediatric Psoriasis Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Topical Treatment
5.2.2 Systemic Treatment
5.3 Market Segment by Type
5.3.1 World Pediatric Psoriasis Treatment Production by Type (2018-2029)
5.3.2 World Pediatric Psoriasis Treatment Production Value by Type (2018-2029)
5.3.3 World Pediatric Psoriasis Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pediatric Psoriasis Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Psoriasis Vulgaris
6.2.2 Pustular Psoriasis
6.2.3 Erythrodermic Psoriasis
6.2.4 Arthropathic Psoriasis
6.3 Market Segment by Application
6.3.1 World Pediatric Psoriasis Treatment Production by Application (2018-2029)
6.3.2 World Pediatric Psoriasis Treatment Production Value by Application (2018-2029)
6.3.3 World Pediatric Psoriasis Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Pediatric Psoriasis Treatment Product and Services
7.1.4 AbbVie Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Pediatric Psoriasis Treatment Product and Services
7.2.4 Amgen Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Details
7.3.2 Johnson and Johnson Major Business
7.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Product and Services
7.3.4 Johnson and Johnson Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson and Johnson Recent Developments/Updates
7.3.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Pediatric Psoriasis Treatment Product and Services
7.4.4 Novartis AG Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Details
7.5.2 Eli Lilly and Company Major Business
7.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Product and Services
7.5.4 Eli Lilly and Company Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.5.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.6 AstraZeneca
7.6.1 AstraZeneca Details
7.6.2 AstraZeneca Major Business
7.6.3 AstraZeneca Pediatric Psoriasis Treatment Product and Services
7.6.4 AstraZeneca Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 AstraZeneca Recent Developments/Updates
7.6.6 AstraZeneca Competitive Strengths & Weaknesses
7.7 Celgene Corporation
7.7.1 Celgene Corporation Details
7.7.2 Celgene Corporation Major Business
7.7.3 Celgene Corporation Pediatric Psoriasis Treatment Product and Services
7.7.4 Celgene Corporation Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Celgene Corporation Recent Developments/Updates
7.7.6 Celgene Corporation Competitive Strengths & Weaknesses
7.8 UCB
7.8.1 UCB Details
7.8.2 UCB Major Business
7.8.3 UCB Pediatric Psoriasis Treatment Product and Services
7.8.4 UCB Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 UCB Recent Developments/Updates
7.8.6 UCB Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Pediatric Psoriasis Treatment Product and Services
7.9.4 Merck Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Product and Services
7.10.4 Boehringer Ingelheim Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 LEO Pharma
7.11.1 LEO Pharma Details
7.11.2 LEO Pharma Major Business
7.11.3 LEO Pharma Pediatric Psoriasis Treatment Product and Services
7.11.4 LEO Pharma Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 LEO Pharma Recent Developments/Updates
7.11.6 LEO Pharma Competitive Strengths & Weaknesses
7.12 Qingdao Vland Biotech
7.12.1 Qingdao Vland Biotech Details
7.12.2 Qingdao Vland Biotech Major Business
7.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Product and Services
7.12.4 Qingdao Vland Biotech Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Qingdao Vland Biotech Recent Developments/Updates
7.12.6 Qingdao Vland Biotech Competitive Strengths & Weaknesses
7.13 Yunnan Botanee Bio-Technology
7.13.1 Yunnan Botanee Bio-Technology Details
7.13.2 Yunnan Botanee Bio-Technology Major Business
7.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product and Services
7.13.4 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Yunnan Botanee Bio-Technology Recent Developments/Updates
7.13.6 Yunnan Botanee Bio-Technology Competitive Strengths & Weaknesses
7.14 Furen Group
7.14.1 Furen Group Details
7.14.2 Furen Group Major Business
7.14.3 Furen Group Pediatric Psoriasis Treatment Product and Services
7.14.4 Furen Group Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Furen Group Recent Developments/Updates
7.14.6 Furen Group Competitive Strengths & Weaknesses
7.15 Jiangsu Kanion Pharmaceutical
7.15.1 Jiangsu Kanion Pharmaceutical Details
7.15.2 Jiangsu Kanion Pharmaceutical Major Business
7.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product and Services
7.15.4 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
7.15.6 Jiangsu Kanion Pharmaceutical Competitive Strengths & Weaknesses
7.16 Tianjin Pacific Pharmaceutical
7.16.1 Tianjin Pacific Pharmaceutical Details
7.16.2 Tianjin Pacific Pharmaceutical Major Business
7.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product and Services
7.16.4 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7.16.6 Tianjin Pacific Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pediatric Psoriasis Treatment Industry Chain
8.2 Pediatric Psoriasis Treatment Upstream Analysis
8.2.1 Pediatric Psoriasis Treatment Core Raw Materials
8.2.2 Main Manufacturers of Pediatric Psoriasis Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pediatric Psoriasis Treatment Production Mode
8.6 Pediatric Psoriasis Treatment Procurement Model
8.7 Pediatric Psoriasis Treatment Industry Sales Model and Sales Channels
8.7.1 Pediatric Psoriasis Treatment Sales Model
8.7.2 Pediatric Psoriasis Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pediatric Psoriasis Treatment Introduction
1.2 World Pediatric Psoriasis Treatment Supply & Forecast
1.2.1 World Pediatric Psoriasis Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Pediatric Psoriasis Treatment Production (2018-2029)
1.2.3 World Pediatric Psoriasis Treatment Pricing Trends (2018-2029)
1.3 World Pediatric Psoriasis Treatment Production by Region (Based on Production Site)
1.3.1 World Pediatric Psoriasis Treatment Production Value by Region (2018-2029)
1.3.2 World Pediatric Psoriasis Treatment Production by Region (2018-2029)
1.3.3 World Pediatric Psoriasis Treatment Average Price by Region (2018-2029)
1.3.4 North America Pediatric Psoriasis Treatment Production (2018-2029)
1.3.5 Europe Pediatric Psoriasis Treatment Production (2018-2029)
1.3.6 China Pediatric Psoriasis Treatment Production (2018-2029)
1.3.7 Japan Pediatric Psoriasis Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pediatric Psoriasis Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pediatric Psoriasis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pediatric Psoriasis Treatment Demand (2018-2029)
2.2 World Pediatric Psoriasis Treatment Consumption by Region
2.2.1 World Pediatric Psoriasis Treatment Consumption by Region (2018-2023)
2.2.2 World Pediatric Psoriasis Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Pediatric Psoriasis Treatment Consumption (2018-2029)
2.4 China Pediatric Psoriasis Treatment Consumption (2018-2029)
2.5 Europe Pediatric Psoriasis Treatment Consumption (2018-2029)
2.6 Japan Pediatric Psoriasis Treatment Consumption (2018-2029)
2.7 South Korea Pediatric Psoriasis Treatment Consumption (2018-2029)
2.8 ASEAN Pediatric Psoriasis Treatment Consumption (2018-2029)
2.9 India Pediatric Psoriasis Treatment Consumption (2018-2029)
3 WORLD PEDIATRIC PSORIASIS TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pediatric Psoriasis Treatment Production Value by Manufacturer (2018-2023)
3.2 World Pediatric Psoriasis Treatment Production by Manufacturer (2018-2023)
3.3 World Pediatric Psoriasis Treatment Average Price by Manufacturer (2018-2023)
3.4 Pediatric Psoriasis Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pediatric Psoriasis Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pediatric Psoriasis Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Pediatric Psoriasis Treatment in 2022
3.6 Pediatric Psoriasis Treatment Market: Overall Company Footprint Analysis
3.6.1 Pediatric Psoriasis Treatment Market: Region Footprint
3.6.2 Pediatric Psoriasis Treatment Market: Company Product Type Footprint
3.6.3 Pediatric Psoriasis Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pediatric Psoriasis Treatment Production Value Comparison
4.1.1 United States VS China: Pediatric Psoriasis Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pediatric Psoriasis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pediatric Psoriasis Treatment Production Comparison
4.2.1 United States VS China: Pediatric Psoriasis Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pediatric Psoriasis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pediatric Psoriasis Treatment Consumption Comparison
4.3.1 United States VS China: Pediatric Psoriasis Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pediatric Psoriasis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pediatric Psoriasis Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pediatric Psoriasis Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023)
4.5 China Based Pediatric Psoriasis Treatment Manufacturers and Market Share
4.5.1 China Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pediatric Psoriasis Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023)
4.6 Rest of World Based Pediatric Psoriasis Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pediatric Psoriasis Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Topical Treatment
5.2.2 Systemic Treatment
5.3 Market Segment by Type
5.3.1 World Pediatric Psoriasis Treatment Production by Type (2018-2029)
5.3.2 World Pediatric Psoriasis Treatment Production Value by Type (2018-2029)
5.3.3 World Pediatric Psoriasis Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pediatric Psoriasis Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Psoriasis Vulgaris
6.2.2 Pustular Psoriasis
6.2.3 Erythrodermic Psoriasis
6.2.4 Arthropathic Psoriasis
6.3 Market Segment by Application
6.3.1 World Pediatric Psoriasis Treatment Production by Application (2018-2029)
6.3.2 World Pediatric Psoriasis Treatment Production Value by Application (2018-2029)
6.3.3 World Pediatric Psoriasis Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Pediatric Psoriasis Treatment Product and Services
7.1.4 AbbVie Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Pediatric Psoriasis Treatment Product and Services
7.2.4 Amgen Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Details
7.3.2 Johnson and Johnson Major Business
7.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Product and Services
7.3.4 Johnson and Johnson Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson and Johnson Recent Developments/Updates
7.3.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Pediatric Psoriasis Treatment Product and Services
7.4.4 Novartis AG Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Details
7.5.2 Eli Lilly and Company Major Business
7.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Product and Services
7.5.4 Eli Lilly and Company Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.5.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.6 AstraZeneca
7.6.1 AstraZeneca Details
7.6.2 AstraZeneca Major Business
7.6.3 AstraZeneca Pediatric Psoriasis Treatment Product and Services
7.6.4 AstraZeneca Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 AstraZeneca Recent Developments/Updates
7.6.6 AstraZeneca Competitive Strengths & Weaknesses
7.7 Celgene Corporation
7.7.1 Celgene Corporation Details
7.7.2 Celgene Corporation Major Business
7.7.3 Celgene Corporation Pediatric Psoriasis Treatment Product and Services
7.7.4 Celgene Corporation Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Celgene Corporation Recent Developments/Updates
7.7.6 Celgene Corporation Competitive Strengths & Weaknesses
7.8 UCB
7.8.1 UCB Details
7.8.2 UCB Major Business
7.8.3 UCB Pediatric Psoriasis Treatment Product and Services
7.8.4 UCB Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 UCB Recent Developments/Updates
7.8.6 UCB Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Pediatric Psoriasis Treatment Product and Services
7.9.4 Merck Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Product and Services
7.10.4 Boehringer Ingelheim Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 LEO Pharma
7.11.1 LEO Pharma Details
7.11.2 LEO Pharma Major Business
7.11.3 LEO Pharma Pediatric Psoriasis Treatment Product and Services
7.11.4 LEO Pharma Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 LEO Pharma Recent Developments/Updates
7.11.6 LEO Pharma Competitive Strengths & Weaknesses
7.12 Qingdao Vland Biotech
7.12.1 Qingdao Vland Biotech Details
7.12.2 Qingdao Vland Biotech Major Business
7.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Product and Services
7.12.4 Qingdao Vland Biotech Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Qingdao Vland Biotech Recent Developments/Updates
7.12.6 Qingdao Vland Biotech Competitive Strengths & Weaknesses
7.13 Yunnan Botanee Bio-Technology
7.13.1 Yunnan Botanee Bio-Technology Details
7.13.2 Yunnan Botanee Bio-Technology Major Business
7.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product and Services
7.13.4 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Yunnan Botanee Bio-Technology Recent Developments/Updates
7.13.6 Yunnan Botanee Bio-Technology Competitive Strengths & Weaknesses
7.14 Furen Group
7.14.1 Furen Group Details
7.14.2 Furen Group Major Business
7.14.3 Furen Group Pediatric Psoriasis Treatment Product and Services
7.14.4 Furen Group Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Furen Group Recent Developments/Updates
7.14.6 Furen Group Competitive Strengths & Weaknesses
7.15 Jiangsu Kanion Pharmaceutical
7.15.1 Jiangsu Kanion Pharmaceutical Details
7.15.2 Jiangsu Kanion Pharmaceutical Major Business
7.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product and Services
7.15.4 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
7.15.6 Jiangsu Kanion Pharmaceutical Competitive Strengths & Weaknesses
7.16 Tianjin Pacific Pharmaceutical
7.16.1 Tianjin Pacific Pharmaceutical Details
7.16.2 Tianjin Pacific Pharmaceutical Major Business
7.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product and Services
7.16.4 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7.16.6 Tianjin Pacific Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pediatric Psoriasis Treatment Industry Chain
8.2 Pediatric Psoriasis Treatment Upstream Analysis
8.2.1 Pediatric Psoriasis Treatment Core Raw Materials
8.2.2 Main Manufacturers of Pediatric Psoriasis Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pediatric Psoriasis Treatment Production Mode
8.6 Pediatric Psoriasis Treatment Procurement Model
8.7 Pediatric Psoriasis Treatment Industry Sales Model and Sales Channels
8.7.1 Pediatric Psoriasis Treatment Sales Model
8.7.2 Pediatric Psoriasis Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pediatric Psoriasis Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pediatric Psoriasis Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pediatric Psoriasis Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pediatric Psoriasis Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Pediatric Psoriasis Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Pediatric Psoriasis Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Pediatric Psoriasis Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Pediatric Psoriasis Treatment Production Market Share by Region (2018-2023)
Table 9. World Pediatric Psoriasis Treatment Production Market Share by Region (2024-2029)
Table 10. World Pediatric Psoriasis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pediatric Psoriasis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pediatric Psoriasis Treatment Major Market Trends
Table 13. World Pediatric Psoriasis Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pediatric Psoriasis Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Pediatric Psoriasis Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pediatric Psoriasis Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pediatric Psoriasis Treatment Producers in 2022
Table 18. World Pediatric Psoriasis Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pediatric Psoriasis Treatment Producers in 2022
Table 20. World Pediatric Psoriasis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pediatric Psoriasis Treatment Company Evaluation Quadrant
Table 22. World Pediatric Psoriasis Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pediatric Psoriasis Treatment Production Site of Key Manufacturer
Table 24. Pediatric Psoriasis Treatment Market: Company Product Type Footprint
Table 25. Pediatric Psoriasis Treatment Market: Company Product Application Footprint
Table 26. Pediatric Psoriasis Treatment Competitive Factors
Table 27. Pediatric Psoriasis Treatment New Entrant and Capacity Expansion Plans
Table 28. Pediatric Psoriasis Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Pediatric Psoriasis Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pediatric Psoriasis Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pediatric Psoriasis Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pediatric Psoriasis Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pediatric Psoriasis Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pediatric Psoriasis Treatment Production Market Share (2018-2023)
Table 37. China Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pediatric Psoriasis Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pediatric Psoriasis Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pediatric Psoriasis Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Market Share (2018-2023)
Table 47. World Pediatric Psoriasis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pediatric Psoriasis Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Pediatric Psoriasis Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Pediatric Psoriasis Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pediatric Psoriasis Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pediatric Psoriasis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pediatric Psoriasis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pediatric Psoriasis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pediatric Psoriasis Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Pediatric Psoriasis Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Pediatric Psoriasis Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pediatric Psoriasis Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pediatric Psoriasis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pediatric Psoriasis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Pediatric Psoriasis Treatment Product and Services
Table 64. AbbVie Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Pediatric Psoriasis Treatment Product and Services
Table 70. Amgen Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson and Johnson Major Business
Table 75. Johnson and Johnson Pediatric Psoriasis Treatment Product and Services
Table 76. Johnson and Johnson Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Johnson and Johnson Recent Developments/Updates
Table 78. Johnson and Johnson Competitive Strengths & Weaknesses
Table 79. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 80. Novartis AG Major Business
Table 81. Novartis AG Pediatric Psoriasis Treatment Product and Services
Table 82. Novartis AG Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis AG Recent Developments/Updates
Table 84. Novartis AG Competitive Strengths & Weaknesses
Table 85. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly and Company Major Business
Table 87. Eli Lilly and Company Pediatric Psoriasis Treatment Product and Services
Table 88. Eli Lilly and Company Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 91. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 92. AstraZeneca Major Business
Table 93. AstraZeneca Pediatric Psoriasis Treatment Product and Services
Table 94. AstraZeneca Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. AstraZeneca Recent Developments/Updates
Table 96. AstraZeneca Competitive Strengths & Weaknesses
Table 97. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 98. Celgene Corporation Major Business
Table 99. Celgene Corporation Pediatric Psoriasis Treatment Product and Services
Table 100. Celgene Corporation Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Celgene Corporation Recent Developments/Updates
Table 102. Celgene Corporation Competitive Strengths & Weaknesses
Table 103. UCB Basic Information, Manufacturing Base and Competitors
Table 104. UCB Major Business
Table 105. UCB Pediatric Psoriasis Treatment Product and Services
Table 106. UCB Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. UCB Recent Developments/Updates
Table 108. UCB Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck Pediatric Psoriasis Treatment Product and Services
Table 112. Merck Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 116. Boehringer Ingelheim Major Business
Table 117. Boehringer Ingelheim Pediatric Psoriasis Treatment Product and Services
Table 118. Boehringer Ingelheim Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 121. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 122. LEO Pharma Major Business
Table 123. LEO Pharma Pediatric Psoriasis Treatment Product and Services
Table 124. LEO Pharma Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. LEO Pharma Recent Developments/Updates
Table 126. LEO Pharma Competitive Strengths & Weaknesses
Table 127. Qingdao Vland Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Qingdao Vland Biotech Major Business
Table 129. Qingdao Vland Biotech Pediatric Psoriasis Treatment Product and Services
Table 130. Qingdao Vland Biotech Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Qingdao Vland Biotech Recent Developments/Updates
Table 132. Qingdao Vland Biotech Competitive Strengths & Weaknesses
Table 133. Yunnan Botanee Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 134. Yunnan Botanee Bio-Technology Major Business
Table 135. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product and Services
Table 136. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Yunnan Botanee Bio-Technology Recent Developments/Updates
Table 138. Yunnan Botanee Bio-Technology Competitive Strengths & Weaknesses
Table 139. Furen Group Basic Information, Manufacturing Base and Competitors
Table 140. Furen Group Major Business
Table 141. Furen Group Pediatric Psoriasis Treatment Product and Services
Table 142. Furen Group Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Furen Group Recent Developments/Updates
Table 144. Furen Group Competitive Strengths & Weaknesses
Table 145. Jiangsu Kanion Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Jiangsu Kanion Pharmaceutical Major Business
Table 147. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product and Services
Table 148. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 150. Tianjin Pacific Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 151. Tianjin Pacific Pharmaceutical Major Business
Table 152. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product and Services
Table 153. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Pediatric Psoriasis Treatment Upstream (Raw Materials)
Table 155. Pediatric Psoriasis Treatment Typical Customers
Table 156. Pediatric Psoriasis Treatment Typical Distributors
Table 1. World Pediatric Psoriasis Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pediatric Psoriasis Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pediatric Psoriasis Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pediatric Psoriasis Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Pediatric Psoriasis Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Pediatric Psoriasis Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Pediatric Psoriasis Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Pediatric Psoriasis Treatment Production Market Share by Region (2018-2023)
Table 9. World Pediatric Psoriasis Treatment Production Market Share by Region (2024-2029)
Table 10. World Pediatric Psoriasis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pediatric Psoriasis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pediatric Psoriasis Treatment Major Market Trends
Table 13. World Pediatric Psoriasis Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pediatric Psoriasis Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Pediatric Psoriasis Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pediatric Psoriasis Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pediatric Psoriasis Treatment Producers in 2022
Table 18. World Pediatric Psoriasis Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pediatric Psoriasis Treatment Producers in 2022
Table 20. World Pediatric Psoriasis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pediatric Psoriasis Treatment Company Evaluation Quadrant
Table 22. World Pediatric Psoriasis Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pediatric Psoriasis Treatment Production Site of Key Manufacturer
Table 24. Pediatric Psoriasis Treatment Market: Company Product Type Footprint
Table 25. Pediatric Psoriasis Treatment Market: Company Product Application Footprint
Table 26. Pediatric Psoriasis Treatment Competitive Factors
Table 27. Pediatric Psoriasis Treatment New Entrant and Capacity Expansion Plans
Table 28. Pediatric Psoriasis Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Pediatric Psoriasis Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pediatric Psoriasis Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pediatric Psoriasis Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pediatric Psoriasis Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pediatric Psoriasis Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pediatric Psoriasis Treatment Production Market Share (2018-2023)
Table 37. China Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pediatric Psoriasis Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pediatric Psoriasis Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pediatric Psoriasis Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Pediatric Psoriasis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Market Share (2018-2023)
Table 47. World Pediatric Psoriasis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pediatric Psoriasis Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Pediatric Psoriasis Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Pediatric Psoriasis Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pediatric Psoriasis Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pediatric Psoriasis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pediatric Psoriasis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pediatric Psoriasis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pediatric Psoriasis Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Pediatric Psoriasis Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Pediatric Psoriasis Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pediatric Psoriasis Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pediatric Psoriasis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pediatric Psoriasis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Pediatric Psoriasis Treatment Product and Services
Table 64. AbbVie Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Pediatric Psoriasis Treatment Product and Services
Table 70. Amgen Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson and Johnson Major Business
Table 75. Johnson and Johnson Pediatric Psoriasis Treatment Product and Services
Table 76. Johnson and Johnson Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Johnson and Johnson Recent Developments/Updates
Table 78. Johnson and Johnson Competitive Strengths & Weaknesses
Table 79. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 80. Novartis AG Major Business
Table 81. Novartis AG Pediatric Psoriasis Treatment Product and Services
Table 82. Novartis AG Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis AG Recent Developments/Updates
Table 84. Novartis AG Competitive Strengths & Weaknesses
Table 85. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly and Company Major Business
Table 87. Eli Lilly and Company Pediatric Psoriasis Treatment Product and Services
Table 88. Eli Lilly and Company Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 91. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 92. AstraZeneca Major Business
Table 93. AstraZeneca Pediatric Psoriasis Treatment Product and Services
Table 94. AstraZeneca Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. AstraZeneca Recent Developments/Updates
Table 96. AstraZeneca Competitive Strengths & Weaknesses
Table 97. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 98. Celgene Corporation Major Business
Table 99. Celgene Corporation Pediatric Psoriasis Treatment Product and Services
Table 100. Celgene Corporation Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Celgene Corporation Recent Developments/Updates
Table 102. Celgene Corporation Competitive Strengths & Weaknesses
Table 103. UCB Basic Information, Manufacturing Base and Competitors
Table 104. UCB Major Business
Table 105. UCB Pediatric Psoriasis Treatment Product and Services
Table 106. UCB Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. UCB Recent Developments/Updates
Table 108. UCB Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck Pediatric Psoriasis Treatment Product and Services
Table 112. Merck Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 116. Boehringer Ingelheim Major Business
Table 117. Boehringer Ingelheim Pediatric Psoriasis Treatment Product and Services
Table 118. Boehringer Ingelheim Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 121. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 122. LEO Pharma Major Business
Table 123. LEO Pharma Pediatric Psoriasis Treatment Product and Services
Table 124. LEO Pharma Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. LEO Pharma Recent Developments/Updates
Table 126. LEO Pharma Competitive Strengths & Weaknesses
Table 127. Qingdao Vland Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Qingdao Vland Biotech Major Business
Table 129. Qingdao Vland Biotech Pediatric Psoriasis Treatment Product and Services
Table 130. Qingdao Vland Biotech Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Qingdao Vland Biotech Recent Developments/Updates
Table 132. Qingdao Vland Biotech Competitive Strengths & Weaknesses
Table 133. Yunnan Botanee Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 134. Yunnan Botanee Bio-Technology Major Business
Table 135. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product and Services
Table 136. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Yunnan Botanee Bio-Technology Recent Developments/Updates
Table 138. Yunnan Botanee Bio-Technology Competitive Strengths & Weaknesses
Table 139. Furen Group Basic Information, Manufacturing Base and Competitors
Table 140. Furen Group Major Business
Table 141. Furen Group Pediatric Psoriasis Treatment Product and Services
Table 142. Furen Group Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Furen Group Recent Developments/Updates
Table 144. Furen Group Competitive Strengths & Weaknesses
Table 145. Jiangsu Kanion Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Jiangsu Kanion Pharmaceutical Major Business
Table 147. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product and Services
Table 148. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 150. Tianjin Pacific Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 151. Tianjin Pacific Pharmaceutical Major Business
Table 152. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product and Services
Table 153. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Pediatric Psoriasis Treatment Upstream (Raw Materials)
Table 155. Pediatric Psoriasis Treatment Typical Customers
Table 156. Pediatric Psoriasis Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Pediatric Psoriasis Treatment Picture
Figure 2. World Pediatric Psoriasis Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pediatric Psoriasis Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 5. World Pediatric Psoriasis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pediatric Psoriasis Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Pediatric Psoriasis Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 10. China Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 12. Pediatric Psoriasis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Pediatric Psoriasis Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pediatric Psoriasis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pediatric Psoriasis Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pediatric Psoriasis Treatment Markets in 2022
Figure 26. United States VS China: Pediatric Psoriasis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pediatric Psoriasis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pediatric Psoriasis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pediatric Psoriasis Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Pediatric Psoriasis Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Market Share 2022
Figure 32. World Pediatric Psoriasis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pediatric Psoriasis Treatment Production Value Market Share by Type in 2022
Figure 34. Topical Treatment
Figure 35. Systemic Treatment
Figure 36. World Pediatric Psoriasis Treatment Production Market Share by Type (2018-2029)
Figure 37. World Pediatric Psoriasis Treatment Production Value Market Share by Type (2018-2029)
Figure 38. World Pediatric Psoriasis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pediatric Psoriasis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pediatric Psoriasis Treatment Production Value Market Share by Application in 2022
Figure 41. Psoriasis Vulgaris
Figure 42. Pustular Psoriasis
Figure 43. Erythrodermic Psoriasis
Figure 44. Arthropathic Psoriasis
Figure 45. World Pediatric Psoriasis Treatment Production Market Share by Application (2018-2029)
Figure 46. World Pediatric Psoriasis Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Pediatric Psoriasis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Pediatric Psoriasis Treatment Industry Chain
Figure 49. Pediatric Psoriasis Treatment Procurement Model
Figure 50. Pediatric Psoriasis Treatment Sales Model
Figure 51. Pediatric Psoriasis Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Pediatric Psoriasis Treatment Picture
Figure 2. World Pediatric Psoriasis Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pediatric Psoriasis Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 5. World Pediatric Psoriasis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pediatric Psoriasis Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Pediatric Psoriasis Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 10. China Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Pediatric Psoriasis Treatment Production (2018-2029) & (K Units)
Figure 12. Pediatric Psoriasis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Pediatric Psoriasis Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Pediatric Psoriasis Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pediatric Psoriasis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pediatric Psoriasis Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pediatric Psoriasis Treatment Markets in 2022
Figure 26. United States VS China: Pediatric Psoriasis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pediatric Psoriasis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pediatric Psoriasis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pediatric Psoriasis Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Pediatric Psoriasis Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pediatric Psoriasis Treatment Production Market Share 2022
Figure 32. World Pediatric Psoriasis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pediatric Psoriasis Treatment Production Value Market Share by Type in 2022
Figure 34. Topical Treatment
Figure 35. Systemic Treatment
Figure 36. World Pediatric Psoriasis Treatment Production Market Share by Type (2018-2029)
Figure 37. World Pediatric Psoriasis Treatment Production Value Market Share by Type (2018-2029)
Figure 38. World Pediatric Psoriasis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pediatric Psoriasis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pediatric Psoriasis Treatment Production Value Market Share by Application in 2022
Figure 41. Psoriasis Vulgaris
Figure 42. Pustular Psoriasis
Figure 43. Erythrodermic Psoriasis
Figure 44. Arthropathic Psoriasis
Figure 45. World Pediatric Psoriasis Treatment Production Market Share by Application (2018-2029)
Figure 46. World Pediatric Psoriasis Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Pediatric Psoriasis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Pediatric Psoriasis Treatment Industry Chain
Figure 49. Pediatric Psoriasis Treatment Procurement Model
Figure 50. Pediatric Psoriasis Treatment Sales Model
Figure 51. Pediatric Psoriasis Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
